Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment

Ann Intern Med. 2021 Mar;174(3):431. doi: 10.7326/L20-1454.

Authors

Ahmad Alamer¹, Charisse Te², Maryam T Fazel²

Affiliations

¹ University of Arizona, Tucson, Arizona, and Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
² Banner - University Medicine and University of Arizona, Tucson, Arizona.

PMID: 33721529
DOI: 10.7326/L20-1454

No abstract available

Publication types

Comment

MeSH terms

Canagliflozin* / adverse effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Myotoxicity
Rosuvastatin Calcium / adverse effects

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Canagliflozin
Rosuvastatin Calcium